πŸ‡ΊπŸ‡Έ FDA
Patent

US 8349391

Radium target and method for producing it

granted A61KA61K51/1282

Quick answer

US patent 8349391 (Radium target and method for producing it) held by Actinium Phamaceuticals, Inc. expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Actinium Phamaceuticals, Inc.
Grant date
Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61K, A61K51/1282